Clinical studies recruiting near Nuremberg

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Klinikum Nürnberg Nord · Eli Lilly and Company · NCT07218380 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Klinikum Nürnberg Nord · Bristol-Myers Squibb · NCT07106762 Transfer Effects of Stationary Bicycle Perturbation Training on Older Adults' Cycling Skills
NA · Friedrich-Alexander-Universität Erlangen-Nürnberg, Institut · University of Erlangen-Nürnberg Medical School · NCT06453473 Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Acute Ischaemic Stroke Due
NA · Klinikum Nürnberg · iVascular S.L.U. · NCT07357285 A Non-interventional, Prospective Study With Benralizumab
Phase N/A · Research Site · AstraZeneca · NCT06422078 Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib +
Phase N/A · Research Site · AstraZeneca · NCT06380738 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Klinikum Nürnberg Nord · Eli Lilly and Company · NCT06890598 International HIT-MED Registry (I-HIT-MED)
Phase N/A · Cnopf'sche Kinderklinik · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Klinikum Nürnberg Nord · Goethe University · NCT02872987 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Klinikum Nürnberg · Boehringer Ingelheim · NCT06531824 Early Catheter-directed Treatment of High Risk Pulmonary Embolism
NA · Klinik für Innere Medizin 8 Schwerpunkt Kardiologie Universi · Leipzig Heart Science gGmbH · NCT06672081 The DefiPace Study
Phase N/A · Klinikum Nürnberg · Institut für Pharmakologie und Präventive Medizin · NCT04804748 Risk Factors for Neuroendocrine Neoplasms
Phase N/A · Bavarian Cancer Registry, Bavarian Health and Food Safety Au · Bavarian Cancer Registry · NCT06282016 Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy
Phase 4 · Klinikum Nürnberg Nord; Gastroenterologie/ Endokrinologie · University of Leipzig · NCT05551299 Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06517719 Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML
Phase 2 · Klinikum Nürnberg-Nord · Technische Universität Dresden · NCT05904106 Pan Tumor Rollover Study
Phase 2 · Local Institution - 0332 · Bristol-Myers Squibb · NCT03899155 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNS
Phase 3 · Universitätsklinik der Paracelsus Medizinischen Privatuniver · University Hospital Freiburg · NCT06830421 Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs)
NA · Klinikum Nürnberg · Société des Produits Nestlé (SPN) · NCT06212427 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site DE010 · Incyte Corporation · NCT07522073 A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Managemen
NA · Augen & Haut Zentrum-Praxis Dr. Jacobi · Dr. Gerhard Mann chem.-pharm. Fabrik GmbH · NCT07593885 European Aortic Data Collection Project
Phase N/A · Klinnikum Nurnberg · Cook Research Incorporated · NCT05896397 A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06830720 Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C M
Phase 1/Phase 2 · Klinkum Nurnberg Paracelsus Medical Unviersity · Revolution Medicines, Inc. · NCT06128551 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Klinikum Nürnberg Nord · Eli Lilly and Company · NCT06119581 IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors
Phase 1/Phase 2 · Klinikum Nürnberg · Immatics Biotechnologies GmbH · NCT05958121 International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Phase 3 · Diakonie Neuendettelsau, Kliniken Hallerwiese / Cnopf'sche K · University Hospital Muenster · NCT04043494 Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Phase 3 · Cnopf'sche Kinderklinik, Onkologie · Martin Schrappe · NCT03643276

Look up another city

Look up another condition